Chembio Diagnostics Total Revenue

Chembio Diagnostics (CEMI) currently reports a total revenue of $48M as of December 2022. That compares with $37M in the prior-year period — up 30.9% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Chembio Diagnostics's total revenue history and peer comparisons.

Chembio Diagnostics's total revenue increased from $37M to $48M — a 30.9% year-over-year increase (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chembio Diagnostics's total revenue of $48M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Chembio Diagnostics reported $48M in total revenue as of December 2022. That compares with $37M in the prior-year period — up 30.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $48M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Chembio Diagnostics, and consider following CEMI for alerts when major investors trade the stock.